Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA: 600222)
China
· Delayed Price · Currency is CNY
5.18
-0.10 (-1.89%)
Dec 25, 2024, 3:00 PM CST
Henan Taloph Pharmaceutical Stock Co.,Ltd Revenue
Henan Taloph Pharmaceutical Stock Co.,Ltd had revenue of 413.42M CNY in the quarter ending September 30, 2024, a decrease of -7.92%. This brings the company's revenue in the last twelve months to 1.97B, down -6.58% year-over-year. In the year 2023, Henan Taloph Pharmaceutical Stock Co.,Ltd had annual revenue of 2.07B with 5.57% growth.
Revenue (ttm)
1.97B
Revenue Growth
-6.58%
P/S Ratio
1.46
Revenue / Employee
836.26K
Employees
2,353
Market Cap
2.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.07B | 109.21M | 5.57% |
Dec 31, 2022 | 1.96B | 356.18M | 22.20% |
Dec 31, 2021 | 1.60B | 187.42M | 13.23% |
Dec 31, 2020 | 1.42B | 105.28M | 8.03% |
Dec 31, 2019 | 1.31B | 117.02M | 9.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition